GALD — Galderma AG Share News
0.000.00%
Last trade - 00:00- CH₣40.44bn
- CH₣42.01bn
- $5.24bn
Swiss stocks - Factors to watch on December 5
Brief: Galderma Says Sculptra Receives EU MDR Certification For Body Indications
UBS upgrades Galderma to 'buy' citing outperformance in Nemluvio, fillers
Swiss stocks - Factors to watch on November 5
Brief: Galderma Receives U.S. FDA Approval For Restylane® Lyft™ For The Enhancement Of The Chin Profile
Europe Research Roundup: BNP Paribas, Evoke, Nordex
Swiss stocks - Factors to watch on October 29
Europe Research Roundup: Dassault Systemes, Fuchs, Nokia
Galderma slips after shareholders sell stake at discount
Brief: Galderma ABO Priced At CHF 130 Per Share, Says Bookrunner
Swiss stocks - Factors to watch on October 28
Brief: Block Trade Galderma Secondary ABB Orders Below CHF 130 Per Share, Risk Missing Says Bookrunner
Brief: Galderma Secondary ABO Total Offering Size C. 20 MM Shares, Says Bookrunner
Brief: Galderma Secondary ABB's Books Covered, Says Bookrunner
Europe Research Roundup: Adidas, Boliden, LSEG
Galderma raises full-year outlook after sales beat, commits to US expansion (updated)
Galderma raises full-year outlook after sales beat, commits to US manufacturing
Galderma rises pre-market after Q3 beat, outlook upgrade
Brief: Galderma 9M Net Sales Up 15% vs Previous Year At Constant Currency